Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Golgin subfamily A member 6-like protein 22 (GOLGA6L22) is a human protein-coding gene with speculative involvement in Golgi apparatus structure and vesicular trafficking, as are other members of the golgin protein family[1][2][8]. The gene shows tissue-specific enrichment (notably in testis) but its precise cellular role and disease mechanisms remain largely unstudied[6]. Although it has been nominally linked to certain cancers based on genomic studies, there is no solid evidence supporting its candidacy as a drug target or clinical biomarker[2][8][3]. GOLGA6L22 does not fall under major molecular target classes and lacks data on function, disease association, targetable domains, or drug interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Golgin subfamily A member 6-like protein 22 (GOLGA6L22).